{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:124886",
      "entity_text" : "glutathione",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0055" ],
      "CellType" : [ "cl:CL:0000236" ]
    }
  },
  "verbose_text" : "Saxagliptin, a novel dipeptidyl peptidase IV (DPP-4) inhibitor, suppresses the degradation of type II collagen in primary human chondrocytes by decreasing MMP, ADAMTS, and ROS production and increasing glutathione levels mediated by p38 / NFkB pathway [XREF_BIBR].",
  "reading_complete" : "2020-08-03T11:17:58Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T10:56:47Z",
  "trigger" : "levels",
  "evidence" : [ "glutathione levels" ],
  "pmc_id" : "7261331",
  "score" : 0
}